en POLSKI
eISSN: 2449-6731
ISSN: 2449-6723
Prenatal Cardiology
Current issue Archive About the journal Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
1/2022
 
Share:
Send email
Share:
abstract:
Review paper

Congenital heart block in fetuses of anti-SSA/SSB-positive mothers – treatment options, review 2021

Monika Opacian-Bojanowska
1
,
Julia Murlewska
2
,
Paulina Kordjalik
2
,
Iwona Strzelecka
3

  1. Paediatric Cardiosurgery, Copernicus PL, Gdansk, Poland
  2. Department of Prenatal Cardiology, Polish Mother’s Memorial Hospital Research Centre, Lodz, Poland
  3. Department of Fetal Malformation Diagnosis and Prevention, Medical University of Lodz, Public Health Faculty, Poland
Prenat Cardio 2022; 12 (1): 7-13
DOI: https://doi.org/10.5114/pcard.2022.119200
Online publish date: 2022/09/06
View full text Get citation
 
PlumX metrics:
Immune-mediated complete heart block (CHB) is one of the most common reasons of fetal bradycardia, burdened with high morbidity, fetal mortality rate up to 19%. Even 70% of survivors require pacemaker implantation after birth or in early childhood. The recurrence rate of CHB in a subsequent pregnancy reaches 19%. Rare incidence of disease in population, limited experience, lack of standard treatment protocols are main issues. This article is a clue to therapeutic indications and options, based on literature review covering years: 2000-2020.
keywords:

fetal heart block, fetal therapy, immune-mediated heart block
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.